Detection of SARS-CoV-2 in fecal samples with different pretreatment methods and PCR kits
Open Access
- 19 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Microbiology
- Vol. 21 (1), 1-7
- https://doi.org/10.1186/s12866-021-02118-0
Abstract
Gastrointestinal symptoms are common in COVID-19 patients and SARS-CoV-2 RNA has been detected in the patients’ feces, which could lead to fecal–oral transmission. Therefore, fecal sample testing with real-time RT-PCR is highly recommended as a routine test for SARS-CoV-2 infection. However, varying rates of detection in fecal sample have been reported. The aim of this study was to provide insights into the detection rates of SARS-CoV-2 in COVID-19 patients’ fecal sample by using four real-time RT-PCR kits and two pretreatment methods (inactive and non-inactive). The detection rate of Trizol pretreatment group was slightly higher than that of Phosphate Buffered Saline (PBS) groups, showing that pretreatment and inactivation by Trizol had no influence to SARS-CoV-2 nucleic acid test (NAT) results. 39.29% detection rate in fecal sample by DAAN was obtained, while Bio-germ was 40.48%, Sansure 34.52%, and GeneoDx 33.33%. The former three kits had no significant difference. The DAAN kit detection rates of ORF1ab and N gene were nearly equal and Ct value distribution was more scattered, while the Bio-germ kit distribution was more clustered. The positive rate of SARS-COV-2 in fecal samples correlated with the severity of the disease, specifically, severe cases were less likely to be identified than asymptomatic infection in the DAAN group (adjusted OR 0.05, 95%CI = 0.00 ~ 0.91). Trizol should be of choice as a valid and safe method for pretreatment of fecal samples of SARS-CoV-2. All real-time RT-PCR kits assessed in this study can be used for routine detection of SARS-CoV-2 in fecal samples. While DAAN, with high NAT positive rate, could be the best out of the 4 kits used in this study. SARS-CoV-2 positive rate in fecal sample was related to the severity of illness.Keywords
This publication has 36 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaThe New England Journal of Medicine, 2020
- Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification testsInternational Journal of Infectious Diseases, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severityEmerging Microbes & Infections, 2020
- Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routesEmerging Microbes & Infections, 2020
- Purification of RNA Using TRIzol (TRI Reagent)Cold Spring Harbor Protocols, 2010
- Molecular Interactions in the Assembly of CoronavirusesPublished by Elsevier BV ,2005
- Virus inactivation by nucleic acid extraction reagentsJournal of Virological Methods, 2004